4 news items
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference
BRKR
26 Apr 24
: "Bruker is committed to innovation in routine microbiology and infectious disease testing. This includes nearly universal microbial identification
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
BRKR
4 Apr 24
offering."
This partnership underscores the commitment of both companies to scientific excellence
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
BRKR
4 Apr 24
underscores the commitment of both companies to scientific excellence and their shared vision of advancing precision medicine through innovative
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
BRKR
7 Mar 24
, maintaining its commitment to industry-leading automated laboratory solutions and customer service
- Prev
- 1
- Next